Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.20
-0.91 (-4.31%)
At close: Aug 14, 2025, 3:59 PM
20.20
0.00%
After-hours: Aug 14, 2025, 04:20 PM EDT

Neurogene Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
925K n/a n/a n/a
Cost of Revenue
3.25M 3.26M 3.2M 2.28M
Gross Profit
-2.32M -3.26M -3.2M -2.28M
Operating Income
-82.61M -55.58M -56.52M -50.53M
Interest Income
8.47M 2.95M 1.34M 19K
Pretax Income
-75.14M -36.32M -55.19M -50.52M
Net Income
-75.14M -36.32M -55.19M -50.52M
Selling & General & Admin
22.61M 11.19M 9.01M 8.27M
Research & Development
60.92M 44.39M 47.51M 42.26M
Other Expenses
-3.25M -3.26M -3.2M -42.26M
Operating Expenses
80.28M 52.32M 53.32M 8.27M
Interest Expense
12K 12K 2K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
83.53M 55.58M 56.52M 50.53M
Income Tax Expense
n/a n/a -5K n/a
Shares Outstanding (Basic)
17.57M 12.82M 12.82M 55.04M
Shares Outstanding (Diluted)
17.57M 12.82M 12.82M 55.04M
EPS (Basic)
-4.28 -2.83 -4.3 -0.92
EPS (Diluted)
-4.28 -2.83 -4.3 -0.92
EBITDA
-71.89M -52.29M -51.99M -49.59M
EBIT
-75.13M -55.58M -55.19M -50.53M
Depreciation & Amortization
3.25M 3.3M 3.2M 947K